Dyadic International, Inc. (DYAI) financial statements (2022 and earlier)

Company profile

Business Address 140 INTRACOASTAL POINTE DRIVE
JUPITER, FL 33477
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments20,260 34,22341,203
Cash and cash equivalents15,748 4,8242,386
Short-term investments4,512 29,39938,816
Receivables372 1,1391,120
Prepaid expense376 278172
Other undisclosed current assets   253
Total current assets:21,008 35,63942,748
Noncurrent Assets
Nontrade receivables  250501
Long-term investments and receivables  1,512 
Long-term investments  1,512 
Other noncurrent assets6 5152
Other undisclosed noncurrent assets285   
Total noncurrent assets:291 1,813553
TOTAL ASSETS:21,299 37,45243,301
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,258 1,509709
Accounts payable1,548 943309
Accrued liabilities710 566400
Deferred revenue151  
Contract with customer, liability79141
Other undisclosed current liabilities147   
Total current liabilities:2,556 1,588850
Noncurrent Liabilities
Other undisclosed noncurrent liabilities353   
Total noncurrent liabilities:353   
Total liabilities:2,909 1,588850
Stockholders' equity
Stockholders' equity attributable to parent18,390 35,86442,451
Common stock40 4039
Treasury stock, value(18,930) (18,930)(18,930)
Additional paid in capital101,026 96,10694,385
Accumulated deficit(63,747) (41,351)(33,043)
Total stockholders' equity:18,390 35,86442,451
TOTAL LIABILITIES AND EQUITY:21,299 37,45243,301

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues2,404 1,6811,295
Realized investment gains1,606   
Cost of revenue(2,041) (2,356)(2,264)
Cost of goods and services sold(1,944) (1,460)(1,027)
Gross profit:363 (675)(968)
Operating expenses(15,090) (8,608)(6,624)
Operating loss:(14,727) (9,283)(7,592)
Nonoperating income (expense)1,657 (198)895
Investment income, nonoperating(330) (198)(677)
Loss from continuing operations before income taxes:(13,070) (9,481)(6,698)
Income tax expense (benefit)  (10)1,006
Net loss:(13,070) (9,491)(5,692)
Other undisclosed net income attributable to parent  1,183 
Net loss available to common stockholders, diluted:(13,070) (8,308)(5,692)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(13,070) (9,491)(5,692)
Comprehensive loss, net of tax, attributable to parent:(13,070) (9,491)(5,692)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: